HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Monday, 19 November 2012

Recent CUAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers.  33 papers were listed this time. Here's a few  in our areas of research interest:

Haim Erder M, Xie J, Signorovitch JE, et al. Cost Effectiveness of Guanfacine Extended-Release versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder: Application of a Matching-Adjusted Indirect Comparison. Appl Health Econ Health Policy. 2012 Nov 1;10(6):381-95. PubMed PMID: 23113551.

Bartsch SM, Curry SR, Harrison LH, et al. The potential economic value of screening hospital admissions for Clostridium difficile. Eur J Clin Microbiol Infect Dis. 2012 Nov;31(11):3163-71. Epub 2012 Jun 30. PubMed PMID: 22752150.

Gajic-Veljanoski O, Bayoumi AM, Tomlinson G, et al. Vitamin K supplementation for the primary prevention of osteoporotic fractures: is it cost-effective and is future research warranted? Osteoporos Int. 2012 Nov;23(11):2681-92. Epub 2012 Mar 8. PubMed PMID: 22398856.

Lippuner K, Johansson H, Borgström F, et al. Cost-effective intervention thresholds against osteoporotic fractures based on FRAX® in Switzerland. Osteoporos Int. 2012 Nov;23(11):2579-89. Epub 2012 Jan 6. PubMed PMID: 22222755.